| Document |
Document Title |
|
WO/2023/176918A1 |
The purpose of the present invention is to provide a metal-organic framework that exhibits an excellent adsorption performance for adsorption target substances. The present invention is a metal-organic framework that has a decomposition ...
|
|
WO/2023/176919A1 |
The purpose of the present invention is to provide an MOF having excellent heat resistance. The metal-organic framework has a structure SM-x which is composed of: an organic ligand; a structure Sx consisting of at least one among O2-, OH...
|
|
WO/2023/157982A1 |
The purpose of the present disclosure is to provide a method for isolating a fluorocarbon having one carbon atom. A fluorocarbon isolation method according to the present disclosure comprises isolating a fluorocarbon having n carbon at...
|
|
WO/2023/152332A1 |
The current invention relates to a method for the production of at least one organometallic compound comprising: filling solid metal particulates or metal containing solid particulates into a reactor column obtaining a metal bed; continu...
|
|
WO/2023/119507A1 |
[Problem] To increase the number of catechol sites for modification in a metal-organic framework. [Solution] This catechol-modified metal-organic framework comprises: a metal organic framework that contains a central metal and an organic...
|
|
WO/2023/119508A1 |
[Problem] To increase metal sites that modify a metal organic framework to increase the adsorption amount of a gas. [Solution] Provided is a metal-modified metal organic framework which comprises a metal organic framework containing a ce...
|
|
WO/2023/118454A1 |
Metal-organic framework material (MOF), comprising at least one metal center and at least one organic compound selected among the compounds according to formula (I): (I) - wherein n is from 1 to 2, - R is –(CH2-CH2-O)m-CH3 with m from ...
|
|
WO/2023/120645A1 |
The purpose of the present invention is to newly provide an organic zinc compound that can be used to synthesize a special amino acid. Provided are an organic zinc compound and a production method for the organic zinc compound.
|
|
WO/2023/106883A1 |
The present invention discloses a novel compound, a method for producing same, and a pharmaceutical composition containing same. The compound according to the present invention is represented by chemical formula 1. In chemical formula 1,...
|
|
WO/2023/106616A1 |
Disclosed in the present invention are a novel compound, a preparation method therefor, and a pharmaceutical composition comprising same. The compound of the present invention is represented by the following chemical formula 1. [Chemical...
|
|
WO/2023/096802A1 |
The disclosure provides methodology for the synthesis of mono-alkylated cyclopentadiene structures, which can be obtained via fulvene intermediates. In one embodiment, the cyclopentadiene ring is substituted with a trialkylsilyl moiety, ...
|
|
WO/2023/086062A1 |
Invention relates to use of antitumoral effective benzimidazole metal complex containing zinc having antitumoral effect, in treatment of cancer. The invention particularly relates to use of 1-(4-chlorobenzyl)benzimidazole and 1-(4-methyl...
|
|
WO/2023/080505A1 |
The present invention relates to an organometallic compound, a method for preparing same, and a method for preparing a thin film using same and, more specifically, to an organometallic compound, a method for preparing same, and a method ...
|
|
WO/2023/071328A1 |
Disclosed is a method for synthesizing 8-amino-1-{[2-(trimethylsilyl)ethoxy]methoxy}octane-3-one, which belongs to the technical field of pharmaceutical chemical synthesis. The method comprises the steps of: firstly, protecting diphenylm...
|
|
WO/2023/071855A1 |
Disclosed are a class of hydrazone-based Zn (II) coordination complex photochromic material, a preparation and a use thereof. Said class of material is a hydrazone-based terpyridine ligand, hydrazone is used as a basis of an optical swit...
|
|
WO/2023/069767A1 |
This present disclosure is directed to methods for detecting and quantifying radioisotopes ( e.g., radiopharmaceuticals) in a liquid and compositions involving the same. Metal-organic frameworks (MOFs) can be synthesized and used for mea...
|
|
WO/2023/058659A1 |
The purpose of the present invention is to provide: a new porous three-dimensional network structure applicable to a crystalline sponge method; a method for producing the porous three-dimensional network structure; and a new structural a...
|
|
WO/2023/036350A1 |
The present invention relates to compounds of general formula (I) for use as complexing agents. The invention further relates to the coordination compounds thereof, peptide conjugates, method of their preparation and use thereof.
|
|
WO/2023/028644A1 |
The present application relates to a metal organic framework (MOF) glass composite comprising metal halide perovskite, and a method for its preparation.
|
|
WO/2023/029620A1 |
The present application provides an organomagnesium compound having a structure represented by the following structural formula (1): the organomagnesium compound is a liquid in a working state, has a stable high saturation vapor pressure...
|
|
WO/2023/022016A1 |
The present invention is a carboxylic acid zinc salt used in manufacturing semiconductor nanoparticles, the carboxylic acid zinc salt being characterized by: being a zinc salt of a carboxylic acid; the proportion of C8-10 carboxylic acid...
|
|
WO/2023/006722A1 |
The invention relates to a process for the manufacturing of a solution of a dimeric gadolinium complex, such as [μ-[1-[bis[2-(hydroxy-κO)-3-[4,7,10-tris[(carboxy-κO)meth
yl]-1,4,7,10-tetraazacyclododec-1-yl-κN1,κN4,κN7,κN10]pr
opy...
|
|
WO/2022/257895A1 |
The present invention relates to an intermediate for fulvestrant and a preparation method therefor. Specifically, the present invention relates to a compound of formula V and a preparation method therefor, wherein R1 is hydrogen or hydro...
|
|
WO/2022/256897A1 |
The present disclosure is directed to chelated nutrients having a structure [M(Ligand 1)(Ligand 2)]2Y, wherein: M is a metal selected from the group consisting of Cu, Mn, Zn, Co, Ni, Mg, Ca and Fe; Ligand 1 is glutamic acid; Ligand 2 is ...
|
|
WO/2022/224950A1 |
Provided is a method for producing an organic compound, said method including a step for repeating an operation in which a liquid containing an organic solvent is passed through a packed column packed with magnesium, a material containin...
|
|
WO/2022/196796A1 |
The first problem addressed by the present invention is to provide a simple method for producing an organic metal nucleophilic agent, the method being reduced in environmental load by reducing the amount of an organic solvent used therei...
|
|
WO/2022/190877A1 |
Provided is a thin film-forming starting material for use in an atomic layer deposition method, which contains a compound represented by general formula (1). (In formula (1), R1, R2 and R3 independently represent a linear or branched alk...
|
|
WO/2022/175927A1 |
Embodiments of the invention generally relate to a method of preparing a metal organic framework (MOF), and specifically a zinc MOF having the formula Zn2Ht2Ox. The method generally comprises contacting at least one cycloazocarbyl compou...
|
|
WO/2022/175111A1 |
The invention relates to a process for preparing compounds of the general formula MAYn(AzuH) (I), where MA = alkali metal, Y = neutral ligand, n = 0, 1, 2, 3 or 4. AzuH is azulene (bicyclo[5.3.0]decapentaene) or an azulene derivative tha...
|
|
WO/2022/176961A1 |
Disclosed is a compound represented by formula (1). In formula (1), n represents an integer of 0-5. Q1, Q2, Q3, and Q4 represent a moiety selected from group A, a moiety selected from group B, a moiety represented by formula (C1), or the...
|
|
WO/2022/165004A1 |
The present invention provides modified alphaviruses and compositions, methods, and kits for preparing and using, in particular AAV viral particles pseudotyped with capsids, in particular for use in gene therapy and/or diagnostics.
|
|
WO/2022/164213A1 |
The present invention relates to a porous carbon structure and a manufacturing method therefor. More specifically, the porous carbon structure comprises a core-shell structured MOF, in which a first MOF contained in a core and a second M...
|
|
WO/2022/152879A1 |
The present invention is directed to solvated crystalline polynuclear metal complexeswhich solvation is with a polar solvent or a mixture of polar and non-polar solvent. These polar solvated crystalline metal complexes of the present inv...
|
|
WO/2022/127713A1 |
Disclosed is a device for continuous liquid alkane introduction in a Grignard reaction. The device comprises a liquid alkane storage tank and a Grignard reaction kettle, which are characterized in that: an outlet of the liquid alkane sto...
|
|
WO/2022/124174A1 |
Provided are: a metal-containing additive containing a β-diketonatometal complex and having excellent storage stability; a crosslinkable-polymer composition; and a crosslinked-polymer material, a metallic member, and a wire harness whic...
|
|
WO/2022/112118A1 |
The present invention relates to the field of organic synthesis. More specifically, it concerns a process for the selective reduction of a C3-C70 substrate containing one or more carbonyl or carboxylic functional groups into the correspo...
|
|
WO/2022/113972A1 |
The present invention addresses the problem of providing a thiabendazole-containing composition for pest control which is reduced in color tone change due to light or heat, is less apt to decompose at high temperatures, and is inhibited ...
|
|
WO/2022/106769A1 |
The invention relates to a diorganomagnesium compound having the formula RB-Mg-RA, where RA is a polymer chain of a 1,3-diene, an aromatic α-monoolefin or a mixture thereof having an amine function, RB comprises a benzene ring substitut...
|
|
WO/2022/107695A1 |
A method for producing barium titanyl oxalate, wherein barium titanyl oxalate is produced by mixing and reacting a solution containing oxalic acid (solution A) and a solution containing a titanium source and a barium source (solution B) ...
|
|
WO/2022/087215A1 |
Provided is a process for the mono-alkylation of cyclopentadiene, utilizing a cyclopentadiene magnesium halide and a metal salt of an alkyl or aryl sulfonate as co-reactant with an alkyl halide alkylating reactant. The process provides f...
|
|
WO/2022/071136A1 |
The present invention relates to fatty acid magnesium salt particles having an aspect ratio represented by formula (1) of 1.0-2.0, wherein the number of carbons in the fatty acid is 12-22 and the average thickness of the fatty acid magne...
|
|
WO/2022/061431A1 |
The present invention relates to a novel compound, dichlorobis(22-hydrazone-imidazoline-2-yl-chol-5-en-3-beta-o
l)zinc(II), which consists of a metalloazasterol that results from complexing zinc with two 22-hydrazone-imidazoline-2-yl-cho...
|
|
WO/2022/061918A1 |
The present application relates to the technical field of chemical pharmacy, and in particular, to a preparation method for 3,5-dihalobenzotrifluoride, comprising: using 3,5-dihalo-4-aminotrifluorotoluene as a raw material, and subjectin...
|
|
WO/2022/042549A1 |
Provided are a tedizolid phosphate intermediate and a preparation method therefor. In the present disclosure, 3-fluoro-4-bromoaniline and a disubstituted amine are taken as starting materials to synthesize a tedizolid phosphate intermedi...
|
|
WO/2022/034313A1 |
The present invention relates to compounds of Formula I: wherein R1, L1, A, Xa, L2, B and Xb are each as defined herein. The present invention also relates to compounds of Formula II and III defined herein, formed by self-assembly of the...
|
|
WO/2022/029078A1 |
The present invention relates to a molding comprising, (i) a polyester in an amount in the range of from 25 to 99.99 weight-%, based on the total weight of the molding, (ii) a metal-organic framework in an amount of from 0.01 to 25 weigh...
|
|
WO/2022/025701A1 |
The present invention relates to a chain transfer agent containing an organozinc compound, a method for preparing same, and a method for preparing a block copolymer using same. A chain transfer agent is obtained by a preparation method c...
|
|
WO/2022/023724A1 |
The present invention relates to compounds, compositions, methods of forming/preparing such compounds and compositions, and uses for sanitising and/or substantially removing biofilms and microorganisms living within or around biofilms. T...
|
|
WO/2022/018430A1 |
A zinc complex of a compound where the zinc complex is either a complex of JBIR-141 and a zinc ion and has the chemical formula C31H48N6O11Zn, or where the zinc complex is a complex of JBIR-142 and a zinc ion and has the chemical formula...
|
|
WO/2022/018425A1 |
Zinc complexes are described which find use in methods of selective hydrogenation of compounds which contain reducible double or triple bonds, such as the reduction of alkynes to alkenes. The zinc complexes have a general structure accor...
|
